Barbara Weiser

Title: Barbara Weiser: Innovator in Antibody Development

Introduction

Barbara Weiser is a prominent inventor based in Sindelsdorf, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of innovative antibodies. With a total of six patents to her name, Weiser has established herself as a key figure in her area of expertise.

Latest Patents

Among her latest patents is an invention related to an antibody that binds to VEGF-A and ANG2, along with methods of use. This invention focuses on anti-VEGF-A/anti-ANG2 antibodies, specifically in the form of a bispecific Fab fragment, and outlines methods for utilizing these antibodies effectively. Another notable patent involves antibodies specific for DR5, which includes bispecific antibodies that contain at least one antigen binding site specific for DR5 and another for FAP. This patent also details methods for their production, pharmaceutical compositions containing these antibodies, and their various uses.

Career Highlights

Throughout her career, Barbara Weiser has worked with esteemed companies such as Hoffmann-La Roche Inc. and Roche Glycart AG. Her work in these organizations has allowed her to contribute to groundbreaking research and development in the field of antibody therapies.

Collaborations

Weiser has collaborated with notable professionals in her field, including Joerg Moelleken and Guy Georges. These partnerships have further enhanced her research and innovation efforts.

Conclusion

Barbara Weiser's contributions to antibody development and her impressive portfolio of patents highlight her significant role in advancing biotechnology. Her work continues to impact the field positively, paving the way for future innovations.